MR liver imaging with Gd-EOB-DTPA: The need for different delay times of the hepatobiliary phase in patients with different liver function
- PMID: 26860666
- DOI: 10.1016/j.ejrad.2015.12.015
MR liver imaging with Gd-EOB-DTPA: The need for different delay times of the hepatobiliary phase in patients with different liver function
Abstract
Purpose: To determine the optimal hepatobiliary delay time after Gd-EOB-DTPA injection for lesion characterization in cirrhosis patients with different liver function.
Materials and methods: Ninety consecutive patients with liver cirrhosis who underwent Gd-EOB-DTPA-enhanced MRI for the evaluation of known or suspected focal liver lesions were enrolled in this retrospective study. The patients were divided into Child-Pugh A, B and C groups depending on their liver function through the Child-Pugh classification. Hepatobiliary phase images obtained at 5, 10, 15, and 20min were assessed in each group by the following items: parenchymal enhancement, contrast agent excretion into the bile ducts and ureter, and contrast- and signal-to-noise ratios for lesions.
Results: In the Child-Pugh A group, parenchymal enhancement increased significantly from 5min to 15min (P<0.05), and stabilized at 20min (P=0.22). However, there was no significant difference in parenchymal enhancement among all of the hepatobiliary phases in the Child-Pugh B and C groups. The biliary contrast agent excretion was first observed before 20min in all of the patients in the Child-Pugh A group, at 20min in 4 patients (25%) in the Child-Pugh B group, and after 20min in 11 patients (78.6%) in the Child-Pugh C group. The numbers of patients whose urethral contrast agent excretion was first observed at 5min in the Child-Pugh A, B and C groups were 38 (63.3%), 12 (75.0%) and 11 (78.6%), respectively. The CNR of the lesions increased significantly (P<0.05), up to 15min after enhancement without a further increase at 20min in the Child-Pugh A group; however, no significant change was found from 5min to 20min in the Child-Pugh B and C groups. For the SNR of lesions, there was no significant difference at 5, 10, 15 and 20min in all of the groups.
Conclusions: A delay time of 15min for the hepatobiliary phase was sufficient for patients with mild liver dysfunction who were classified as Child-Pugh A. Nevertheless, for the patients with moderate or severe liver dysfunction who were classified as Child-Pugh B or C, a delay time longer than 5min is meaningless for lesion characterization.
Keywords: Delay time; Gd-EOB-DTPA; Hepatobiliary phase; Liver cirrhosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
MR liver imaging with Gd-EOB-DTPA: a delay time of 10 minutes is sufficient for lesion characterisation.Eur Radiol. 2012 Oct;22(10):2153-60. doi: 10.1007/s00330-012-2486-2. Epub 2012 May 30. Eur Radiol. 2012. PMID: 22645040 Free PMC article.
-
Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.World J Gastroenterol. 2018 Jan 21;24(3):415-423. doi: 10.3748/wjg.v24.i3.415. World J Gastroenterol. 2018. PMID: 29391764 Free PMC article.
-
Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.Eur J Radiol. 2011 Dec;80(3):e311-6. doi: 10.1016/j.ejrad.2011.01.020. Epub 2011 Feb 18. Eur J Radiol. 2011. PMID: 21315529
-
Primovist, Eovist: what to expect?J Hepatol. 2012 Aug;57(2):421-9. doi: 10.1016/j.jhep.2012.01.031. Epub 2012 Apr 12. J Hepatol. 2012. PMID: 22504332 Review.
-
MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent Gd-EOB-DTPA.Magn Reson Med Sci. 2007;6(1):43-52. doi: 10.2463/mrms.6.43. Magn Reson Med Sci. 2007. PMID: 17510541 Review.
Cited by
-
Predicting the recurrence of hepatocellular carcinoma (≤ 5 cm) after resection surgery with promising risk factors: habitat fraction of tumor and its peritumoral micro-environment.Radiol Med. 2023 Oct;128(10):1181-1191. doi: 10.1007/s11547-023-01695-6. Epub 2023 Aug 19. Radiol Med. 2023. PMID: 37597123
-
Evaluation of liver function in patients with liver cirrhosis and chronic liver disease using functional liver imaging scores at different acquisition time points.Front Genet. 2022 Dec 6;13:1071025. doi: 10.3389/fgene.2022.1071025. eCollection 2022. Front Genet. 2022. PMID: 36561314 Free PMC article.
-
A convenient and reproducible protocol for acquisition of the hepatocyte phase for liver function-impaired patients in gadoxetic acid disodium-enhanced magnetic resonance imaging.Quant Imaging Med Surg. 2024 Feb 1;14(2):1904-1915. doi: 10.21037/qims-23-1147. Epub 2024 Jan 18. Quant Imaging Med Surg. 2024. PMID: 38415116 Free PMC article.
-
Optimization of hepatobiliary phase imaging in gadoxetic acid-enhanced magnetic resonance imaging: a narrative review.Quant Imaging Med Surg. 2023 Mar 1;13(3):1972-1982. doi: 10.21037/qims-22-916. Epub 2023 Feb 10. Quant Imaging Med Surg. 2023. PMID: 36915322 Free PMC article. Review.
-
Structure guided deformable image registration for treatment planning CT and post stereotactic body radiation therapy (SBRT) Primovist® (Gd-EOB-DTPA) enhanced MRI.J Appl Clin Med Phys. 2019 Dec;20(12):109-118. doi: 10.1002/acm2.12773. Epub 2019 Nov 22. J Appl Clin Med Phys. 2019. PMID: 31755658 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical